Zhitong Finance App News, Lizhu Pharmaceutical (01513.HK) issued an announcement. On December 7, 2025, the National Health Insurance Administration and the Ministry of Human Resources and Social Security issued the “National Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (Medical Insurance Distribution (2025) No. 33, hereinafter referred to as the “National Medical Insurance Catalogue”). The details of the Group's products are now included in the “National Health Insurance Catalogue” as follows: In 2025, a total of 194 products were included in the “National Health Insurance Catalogue”, including 92 Class A and 102 Class B. Among them: injectable ariprazole microspheres were included in the national medical insurance catalogue for the first time through negotiations, injectable triprarelin acetate microspheres added new indications, and the injectable iprazole sodium contract was successfully renewed.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Lizhu Pharmaceutical (01513.HK) issued an announcement. On December 7, 2025, the National Health Insurance Administration and the Ministry of Human Resources and Social Security issued the “National Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (Medical Insurance Distribution (2025) No. 33, hereinafter referred to as the “National Medical Insurance Catalogue”). The details of the Group's products are now included in the “National Health Insurance Catalogue” as follows: In 2025, a total of 194 products were included in the “National Health Insurance Catalogue”, including 92 Class A and 102 Class B. Among them: injectable ariprazole microspheres were included in the national medical insurance catalogue for the first time through negotiations, injectable triprarelin acetate microspheres added new indications, and the injectable iprazole sodium contract was successfully renewed.